Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BP vs GSK✓SelectedUSD · GSKBP vs GSK performance historyLatest closeAs of-1.06%11/20
Stock and ETF performance explorer

BP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+117.2%
GSK return
+97.4%
Excess return
+19.8%
Maximum drawdown
-63.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-0.1%-0.9%-1.0%
7D-6.5%-5.3%-1.1%-4.6%
30D-13.3%-3.7%-9.6%-12.3%
3M-4.2%-7.3%+3.0%-2.1%
6M-3.0%-4.2%+1.2%-2.6%
YTD+29.1%+0.9%+28.3%+25.3%
1Y+25.6%+7.3%+18.3%+18.6%
3Y+39.9%+52.7%-12.9%+7.3%
5Y+109.0%+40.1%+68.9%+64.4%
All+117.2%+97.4%+19.8%+45.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling